![logo](/logos/MXCT.webp)
MaxCyte, Inc.
NASDAQ:MXCT
3.79 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | MaxCyte, Inc. |
Symbool | MXCT |
Munteenheid | USD |
Prijs | 3.79 |
Beurswaarde | 398,288,106 |
Dividendpercentage | 0% |
52-weken bereik | 2.45 - 5.545 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Douglas Arthur Doerfler |
Website | https://maxcyte.com |
An error occurred while fetching data.
Over MaxCyte, Inc.
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)